name

EXENATIDE-PD - A randomised, double blind, placebo controlled, single centre, 60 week trial of Exenatide once weekly for the treatment of moderate severity Parkinson’s disease

EudraCT: 2013-003363-64                       ISRCTN: 75891427



                                         
pd1


                                         



                                         

RECRUITMENT TARGET = 60

ACTUAL RECRUITMENT = 60 (trial has recruited enough participants to date = recruitment closed on 13-Mar-2015)

EXENATIDE-PD Management Office

Comprehensive Clinical Trials Unit

University College London

Gower Street, London, WC1E 6BT

email: exenatidepd@ucl.ac.uk